Alluvi tirzepatide has been emerged as a promising therapeutic agent for the management of metabolic disorders. Alluvi Tirzepatide 40mg (R&D Only) This exploratory evaluation assessed the efficacy and safety of tirzepatide 40mg in animal models of insulin resistance. The experiments demonstrated that tirzepatide 40mg markedly enhanced glycemic cont